SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-040526
Filing Date
2021-08-04
Accepted
2021-08-04 09:14:00
Documents
6
Period of Report
2021-08-04

Document Format Files

Seq Description Document Type Size
1 6-K tlc-6k_20210804.htm 6-K 26380
2 EX-99.1 tlc-ex991_9.htm EX-99.1 681744
3 EX-99.2 tlc-ex992_10.htm EX-99.2 1548377
4 EX-99.3 tlc-ex993_187.htm EX-99.3 30949
5 EX-99.4 tlc-ex994_207.htm EX-99.4 17029
6 GRAPHIC giv0mmmtnjrc000001.jpg GRAPHIC 2942
  Complete submission text file 0001564590-21-040526.txt   2309736
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 211142546
SIC: 2834 Pharmaceutical Preparations